Fig. 1From: Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trialsStudy design. FF, fluticasone furoate; UMEC, umeclidinium; V, visit; VI, vilanterol.Back to article page